BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 24959685)

  • 1. Structure-based prediction of asparagine and aspartate degradation sites in antibody variable regions.
    Sydow JF; Lipsmeier F; Larraillet V; Hilger M; Mautz B; Mølhøj M; Kuentzer J; Klostermann S; Schoch J; Voelger HR; Regula JT; Cramer P; Papadimitriou A; Kettenberger H
    PLoS One; 2014; 9(6):e100736. PubMed ID: 24959685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous assessment of Asp isomerization and Asn deamidation in recombinant antibodies by LC-MS following incubation at elevated temperatures.
    Diepold K; Bomans K; Wiedmann M; Zimmermann B; Petzold A; Schlothauer T; Mueller R; Moritz B; Stracke JO; Mølhøj M; Reusch D; Bulau P
    PLoS One; 2012; 7(1):e30295. PubMed ID: 22272329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure Based Prediction of Asparagine Deamidation Propensity in Monoclonal Antibodies.
    Yan Q; Huang M; Lewis MJ; Hu P
    MAbs; 2018; 10(6):901-912. PubMed ID: 29958069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deciphering deamidation and isomerization in therapeutic proteins: Effect of neighboring residue.
    Irudayanathan FJ; Zarzar J; Lin J; Izadi S
    MAbs; 2022; 14(1):2143006. PubMed ID: 36377085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asparagine Deamidation in a Complementarity Determining Region of a Recombinant Monoclonal Antibody in Complex with Antigen.
    Nowak C; Tiwari A; Liu H
    Anal Chem; 2018 Jun; 90(11):6998-7003. PubMed ID: 29712431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A method for the detection of asparagine deamidation and aspartate isomerization of proteins by MALDI/TOF-mass spectrometry using endoproteinase Asp-N.
    Kameoka D; Ueda T; Imoto T
    J Biochem; 2003 Jul; 134(1):129-35. PubMed ID: 12944379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of deamidation and isomerization sites on pharmaceutical recombinant antibody using H(2)(18)O.
    Terashima I; Koga A; Nagai H
    Anal Biochem; 2007 Sep; 368(1):49-60. PubMed ID: 17617368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation considerations for proteins susceptible to asparagine deamidation and aspartate isomerization.
    Wakankar AA; Borchardt RT
    J Pharm Sci; 2006 Nov; 95(11):2321-36. PubMed ID: 16960822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isomerization of an aspartic acid residue in the complementarity-determining regions of a recombinant antibody to human IgE: identification and effect on binding affinity.
    Cacia J; Keck R; Presta LG; Frenz J
    Biochemistry; 1996 Feb; 35(6):1897-903. PubMed ID: 8639672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of asparagine deamidation and aspartate isomerization in recombinant human interleukin-11.
    Zhang W; Czupryn JM; Boyle PT; Amari J
    Pharm Res; 2002 Aug; 19(8):1223-31. PubMed ID: 12240950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deamidation of asparagine to aspartate destabilizes Cu, Zn superoxide dismutase, accelerates fibrillization, and mirrors ALS-linked mutations.
    Shi Y; Rhodes NR; Abdolvahabi A; Kohn T; Cook NP; Marti AA; Shaw BF
    J Am Chem Soc; 2013 Oct; 135(42):15897-908. PubMed ID: 24066782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting deamidation and isomerization sites in therapeutic antibodies using structure-based
    Hoffmann D; Bauer J; Kossner M; Henry A; Karow-Zwick AR; Licari G
    MAbs; 2024; 16(1):2333436. PubMed ID: 38546837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspartate isomerization in the complementarity-determining regions of two closely related monoclonal antibodies.
    Wakankar AA; Borchardt RT; Eigenbrot C; Shia S; Wang YJ; Shire SJ; Liu JL
    Biochemistry; 2007 Feb; 46(6):1534-44. PubMed ID: 17279618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometric analysis of asparagine deamidation and aspartate isomerization in polypeptides.
    Yang H; Zubarev RA
    Electrophoresis; 2010 Jun; 31(11):1764-72. PubMed ID: 20446295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein asparagine deamidation prediction based on structures with machine learning methods.
    Jia L; Sun Y
    PLoS One; 2017; 12(7):e0181347. PubMed ID: 28732052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of in vivo site-specific Asp isomerization and Asn deamidation of mAbs in animal serum using IP-LC-MS.
    Mehl JT; Sleczka BG; Ciccimaro EF; Kozhich AT; Gilbertson DG; Vuppugalla R; Huang CS; Stevens B; Mo J; Deyanova EG; Wang Y; Huang RY; Chen G; Olah TV
    Bioanalysis; 2016 Aug; 8(15):1611-1622. PubMed ID: 27397670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of isoaspartate at two distinct sites during in vitro aging of human growth hormone.
    Johnson BA; Shirokawa JM; Hancock WS; Spellman MW; Basa LJ; Aswad DW
    J Biol Chem; 1989 Aug; 264(24):14262-71. PubMed ID: 2760065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of asparagine deamidation in a SOD1-based biosynthetic human insulin precursor by MALDI-TOF mass spectrometry.
    Bierczyńska-Krzysik A; Łopaciuk M; Pawlak-Morka R; Stadnik D
    Acta Biochim Pol; 2014; 61(2):349-57. PubMed ID: 24936522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent highly sensitive characterization of asparagine deamidation and aspartic acid isomerization by sheathless CZE-ESI-MS/MS.
    Gahoual R; Beck A; François YN; Leize-Wagner E
    J Mass Spectrom; 2016 Feb; 51(2):150-8. PubMed ID: 26889931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of deamidation and isomerization in β2-microglobulin by 18O labeling.
    Fukuda M; Takao T
    Anal Chem; 2012 Dec; 84(23):10388-94. PubMed ID: 23126476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.